A loss of GATA3 function was consistently seen in high-grade invasive bladder cancer, suggesting the utility of GATA3 as a prognostic biomarker in addition to its utility in diagnostic procedures [50]. The gene discussed is GATA3; the disease is urinary bladder cancer.